¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"brain purpura"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • factitious purpura
    ÀΰøÀÚ»ö¹Ý
  • flat purpura
    ÆíÆòÀÚ»ö¹Ý
  • fulminans purpura
    Àü°ÝÀÚ»ö¹Ýº´, µ¹¹ßÀÚ»ö¹Ýº´
  • gangrenous purpura
    ±«ÀúÀÚ»ö¹Ý
  • hyperglobulinemic purpura
    °í±Û·ÎºÒ¸°Ç÷ÀÚ»ö¹Ý
  • hemorrhagic purpura
    ÃâÇ÷ÀÚ»ö¹Ý
  • Henoch-Schonlein purpura
    Çì³ëÈå-¼é¶óÀÎÀÚ»ö¹Ý
  • Henoch-Schonlein purpura nephritis
    Çì³ëÈå-¼é¶óÀÎÀÚ»ö¹ÝÄáÆÏ¿°, Çì³ëÈå-¼é¶óÀÎÀÚ»ö¹Ý½ÅÀå¿°
  • itching purpura
    °¡·Á¿òÀÚ(»ö)¹Ý
  • immune thrombocytopenic purpura
    ¸é¿ª¼ºÀúÇ÷¼ÒÆÇÀÚ(»ö)¹Ý
  • idiopathic thrombocytopenic purpura
    Ư¹ßÀúÇ÷¼ÒÆÇÀÚ»ö¹Ýº´
  • necrotic purpura
    ±«»çÀÚ»ö¹Ý
  • neonatal purpura
    ½Å»ý¾ÆÀÚ»ö¹Ý
  • orthostatic purpura
    ±â¸³ÀÚ»ö¹Ý
  • obstructive purpura
    Æó¼âÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • gangrenous purpura
    ±«ÀúÀÚ»ö¹Ý
  • hemorrhagic purpura
    ÃâÇ÷ÀÚ»ö¹Ý
  • hyperglobulinemic purpura
    °í±Û·ÎºÒ¸°Ç÷ÀÚ»ö¹Ý
  • idiopathic thrombocytopenic purpura
    Ư¹ßÇ÷¼ÒÆÇ°¨¼ÒÀÚ»ö¹Ýº´
  • itching purpura
    °¡·Á¿îÀÚ»ö¹Ý
  • necrotic purpura
    ±«»çÀÚ»ö¹Ý
  • neonatal purpura
    ½Å»ý¾ÆÀÚ»ö¹Ý
  • obstructive purpura
    Æó¼âÀÚ»ö¹Ý
  • orthostatic purpura
    ±â¸³ÀÚ»ö¹Ý
  • purpura
    ÀÚ»ö¹Ý, ÀÚ»ö¹Ýº´
  • purpura annularis telangiectodes
    ¸ð¼¼Ç÷°üÈ®Àå°í¸®ÀÚ»ö¹Ý
  • purpura erythematosa
    È«¹ÝÀÚ»ö¹Ý
  • palpable purpura
    ÃËÁöÀÚ»ö¹Ý
  • posttransfusion purpura
    ¼öÇ÷ÈÄÀÚ»ö¹Ý
  • psychogenic purpura
    Á¤½ÅÀÚ»ö¹Ý
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • post transfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ(âÃúìý­í¹Úèñø)
  • posttransfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ.
  • posttransfusion purpura
    ¼ö¼úÈÄÀÚ¹Ý(â¢âúý­í¹Úè)
  • posttransfusion purpura=PTP
    ¼öÇ÷ÈÄ ÀÚ¹ÝÁõ
  • psychogenic purpura
    ½ÉÀμºÀÚ¹Ý
  • purpura
    ÀÚ¹Ý(í¹Úè)
  • purpura
    ÀÚ¹ÝÁõ
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý(¡­àõí¹Úè).
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý(¡­àõ í¹Úè)
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý(¡­àõí¹Úè)
  • purpura annularis telangiectodes
    ¸ð¼¼Ç÷°üÈ®À强 ȯ»ó ÀÚ¹Ý
  • purpura bullosa
    ´ë¼öÆ÷¼º(ÓÞâ©øÜàõ) ÀÚ¹Ý.
  • purpura bullosa
    ´ë¼öÆ÷¼º ÀÚ¹Ý(ÓÞâ©øÜàõ í¹Úè)
  • purpura erythematosa
    È«¹Ý¼º(ûõÚèàõ) ÀÚ¹Ý.
  • purpura erythematosa
    È«¹Ý¼º ÀÚ¹Ý(ûõÚèàõ í¹Úè)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • neonatal purpura
    ½Å»ý¾Æ ÀÚ¹Ý
  • neonatal purpura fulminans
    Àü°Ý¼º ½Å»ý¾ÆÀÚ¹Ý
  • nonthrombocytopenic purpura
    Ç÷¼ÒÆÇºñ°¨¼Ò¼º Àڹݺ´
  • obstructive purpura
    Æó¼â¼º ÀÚ¹Ý
  • orthostatic purpura
    ±â¸³¼º Àڹݺ´.
  • palpable purpura
    ÃËÁö¼º ÀÚ¹Ý(º´)
  • post transfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ(âÃúìý­í¹Úèñø)
  • posttransfusion purpura
    ¼öÇ÷ÈÄÀÚ¹ÝÁõ.
  • posttransfusion purpura
    ¼ö¼úÈÄÀÚ¹Ý(â¢âúý­í¹Úè)
  • posttransfusion purpura=PTP
    ¼öÇ÷ÈÄ ÀÚ¹ÝÁõ
  • psychogenic purpura
    ½ÉÀμºÀÚ¹Ý
  • purpura
    ÀÚ¹Ý(í¹Úè)
  • purpura
    ÀÚ¹ÝÁõ
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý(¡­àõí¹Úè).
  • purpura allergica
    ¾Ë·¯Áö¼º ÀÚ¹Ý(¡­àõ í¹Úè)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AITP autoimmune idiopathic thrombocytopenic purpura
ATP adenosine triphosphate; ambient temperature and pressure; autoimmune thrombocytopenic purpura
CPP cancer proneness phenotype; canine pancreatic polypeptide; cerebral perfusion pressure; chest pain p...
HGP hepatic glucose production; hyperglobulinemic purpura
HPW hypergammaglobulinemic purpura of Waldenstrom
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
AP anaphylactoid purpura
ABI Acquired Brain Injury
ABEP Auditory Brain Stem Evoked Potentials
ABR Auditory Brain Stem Response
ABR Auditory brain stem
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • brain weight
    ³ú Áß·®
  • chronic organic brain syndrome
    ¸¸¼º ±âÁú¼º ³ú ÁõÈıº
  • concussion of the brain
    ³ú ÁøÅÁ
    ³úÁøÅÁÀ̶õ ¶óƾ¾îÀÇ Concutere Áï Èçµç´Ù¶ó´Â ¶æÀÌ¸ç µÎºÎ ¿Ü»óÀ» ¹Þ¾Æ ¹Ý°íüÀÎ ³ú°¡ ´Ü´ÜÇÑ µÎ °³ °­ ¾È¿¡¼­ Èçµé·Á ÀϽÃÀûÀ¸·Î ³úÀÇ ±â´ÉÀÌ ÁߴܵǾú´Ù°¡ ¿ÏÀüÈ÷ ȸº¹µÇ¸ç ³ú ½ÇÁú¿¡ ±âÁúÀû º¯È­¸¦ ÀÏÀ¸Å°Áö ¾Ê´Â °¡¿ªÀûÀÎ °æÇÑ ³ú ¼Õ»óÀ¸·Î ±ÔÁ¤µÇ¾î ¿Ô´Ù. ±ÙÀÚ¿¡´Â ³ú ÁøÅÁÀ» ±âÁúÀû ³ú ¼Õ»óÀÇ ¿¬¼Ó¼±»ó¿¡ ÀÖ´Â ÇÑ À¯ÇüÀ¸·Î º¸¸ç, °æ¹ÌÇÑ ÇüÅÂÀÇ ¹Ì¸¸¼º Ãà»è ¼Õ»óÀ¸·Î º¸´Â Ãß¼¼¿¡ ÀÖ´Ù. ³úÁøÅÁ¿¡ ÀÇÇÑ ÀÇ½Ä »ó½Ç°ú ´õºÒ¾î ¿Ü»ó¼º ±â¾ï »ó½ÇÁõÀÌ ¹ß»ýÇϴµ¥, ±ú¾î³­ ÈÄ¿¡ ¿Ü»ó Á÷Àü ¶Ç´Â ¿Ü»ó Á÷ÈÄÀÇ ±â¾ïÀÌ ¼Ò½ÇµÊÀ¸·Î ¿ªÇ༺ ±â¾ï »ó½ÇÁõÀ̶ó°í ºÒ¸®¿ì¸ç ÀÌ·¯ÇÑ Çö»óÀº ´ë°³ 1ÀÏ ÀÌ»ó °è¼ÓµÇÁö ¾ÊÁö¸¸ °æ¿ì¿¡ µû¶ó¼­´Â ¸çÄ¥ ¶Ç´Â ¸î °³¿ù°£ Áö¼ÓµÇ´Â ¼ö°¡ ÀÖ´Ù. ¼Õ»óÀÇ Á¤µµ¿¡ µû¶ó ÀÇ½Ä »ó½Ç°ú ´õºÒ¾î Ç÷¾Ð »ó½Â, ¸Æ¹ÚÀÇ º¯È­, È£Èí ¸¶ºñ, µ¿°ø »ê´ë, ¹ßÇÑ ¹× ¹Ý»çÀÇ ¼Ò½ÇÀÌ ¹ß»ýµÇ±âµµ ÇÏ¸ç ±â´É ¼Ò½ÇÀÇ Á¤µµ¿Í ±â°£Àº ±ÇÅõ¿Í °°Àº ¿îµ¿¿¡¼­ º¼ ¼ö ÀÖ´Â ¹Ýº¹µÈ Ãæ°Ý¿¡ ÀÇÇØ ´©ÀûµÇ°í Áõ´ëµÈ´Ù.
  • degenerative brain disease
    ÅðÇ༺ ³ú Áúȯ
  • fluid brain barrier
    ü¾× ³ú À庮
  • functional brain imaging
    ±â´ÉÀû ³ú ¿µ»ó
  • hind brain
    Èijú
  • olfactory brain
    Èijú
  • organic brain syndrome
    À¯±â¼º ³ú ÁõÈıº, ±âÁú¼º ³ú ÁõÈıº
    ´ë³ú Á¶Á÷ÀÇ ±â´É ÀúÇÏ·Î ¾ß±âµÇ°Å³ª µ¿¹ÝµÇ´Â Á¤½Å Àå¾Ö·Î¼­, À̰ÍÀº Á¤½Åº´¼º
  • smell-brain
    Èijú
  • vein of brain stem
    ³úÁÙ±â Á¤¸Æ
  • wet brain
    ºÎÁ¾ ³ú
  • whole brain irradiation
    Àü³ú Á¶»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
hyperglobulinemic purpura A condition characterised by proliferation of cells resembling lymphocytes or plasma cells in the bone marrow, anaemia, increased sedimentation rate and hyperglobulinaemia. Physical findings include mucosal bleeding, skin purpura and enlargement of the lymph nodes, liver and spleen.
(27 Sep 1997)
nonthrombocytopenic purpura The eruption of petechiae or larger ecchymoses, usually unaccompanied by constitutional symptoms and not associated with systemic illness.
Synonym: nonthrombocytopenic purpura.
(05 Mar 2000)
idiopathic thrombocytopenia purpura <haematology> A rare autoimmune disorder characterised by an acute shortage of platelets with resultant bruising and spontaneous bleeding.
The platelet count becomes exceedingly low and spontaneous bleeding from the gums, gastrointestinal tract and nose can be seen. Physical examination may demonstrate enlargement of the spleen. A typical rash occurs to do microscopic haemorrhage of small blood vessels in the skin.
Platelet counts under 10,000 can lead to spontaneous haemorrhage into the brain causing death. Treatment with corticosteroids is generally effective. Surgical removal of the spleen (splenectomy) is reserved for some patients.
Anti-platelet antibodies are detectable in some cases. It may present in either an acute or a chronic form.
Acronym: ITP
(20 Sep 2002)
idiopathic thrombocytopenic purpura <haematology> A rare autoimmune disorder characterised by an acute shortage of platelets with resultant bruising and spontaneous bleeding.
The platelet count becomes exceedingly low and spontaneous bleeding from the gums, gastrointestinal tract and nose can be seen. Physical examination may demonstrate enlargement of the spleen. A typical rash occurs to do microscopic haemorrhage of small blood vessels in the skin.
Platelet counts under 10,000 can lead to spontaneous haemorrhage into the brain causing death. Treatment with corticosteroids is generally effective. Surgical removal of the spleen (splenectomy) is reserved for some patients.
Anti-platelet antibodies are detectable in some cases. It may present in either an acute or a chronic form.
Acronym: ITP
(20 Sep 2002)
immune thrombocytopenic purpura <haematology> A low number of platelets in the blood, which is common in people with HIV, but often resolves as immune deficiency worsens. HIV-related ITP usually does not have serious consequences. Its cause has not been definitely determined. Treatment with AZT frequently alleviates the condition.
(09 Oct 1997)
thrombocytopenia purpura <haematology> In severe thrombocytopenia, bleeding into skin leads to small petechial haemorrhages.
Primary thrombocytopenia purpura is of unknown cause but results from an autoimmune mechanism that causes platelet destruction.
Secondary thrombocytopenic purpura may result from drug-induced type II hypersensitivity in which platelets coated with antibody to the drug (which is acting as a hapten) are destroyed in a complement mediated reaction. It can also follow a viral upper respiratory infection and may be seen in association with lupus.
(15 Oct 1997)
thrombocytopenic purpura See: idiopathic thrombocytopenic purpura.
(05 Mar 2000)
thrombopenic purpura idiopathic thrombocytopenia purpura
thrombotic thrombocytopenic purpura A rapidly fatal or occasionally protracted disease with varied symptoms in addition to purpura, including signs of central nervous system involvement, due to formation of fibrin or platelet thrombi in arterioles and capillaries in many organs.
Synonym: Moschcowitz' disease.
(05 Mar 2000)
equine nonthrombocytopenic purpura <veterinary> An immune-mediated vasculitis of horses due to immune complex deposition, characteristically as a sequela of strangles.
(05 Mar 2000)
factitious purpura Self-induced, often painful, ecchymoses.
(05 Mar 2000)
fibrinolytic purpura Purpura in which the bleeding is associated with rapid fibrinolysis of the clot.
(05 Mar 2000)
acute brain syndrome <syndrome> A condition of severe confusion or rapid change in brain function. This often occurs as the result of a mental illness or physical illness.
Symptoms include lethargy, agitation, confusion, disorientation and delirium.
(27 Sep 1997)
acute organic brain syndrome <syndrome> A constellation of behavioural or psychological signs and symptoms including problems with attention, concentration, memory, confusion, anxiety, and depression caused by transient or permanent dysfunction of the brain.
Synonym: acute organic brain syndrome, OBS, organic mental syndrome.
(05 Mar 2000)
anterior part of anterior commissure of brain The anterior part of the anterior or rostral commissure of the brain.
Synonym: pars anterior commissurae rostralis, pars anterior commissurae anterioris cerebri.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á